CCDC107 inhibitors are chemical agents that specifically target and modulate the activity of the CCDC107 protein, a coiled-coil domain-containing protein 107, known to play a role in cellular processes related to membrane trafficking and ion channel regulation. CCDC107 is a relatively underexplored protein with complex cellular functions, which makes it an intriguing target for biochemical studies. These inhibitors are typically designed to disrupt the normal function or expression of CCDC107 by binding to specific sites on the protein or interfering with its interactions with other cellular components. By inhibiting CCDC107, researchers can investigate the structural and functional consequences of its absence or alteration within cellular environments, offering insights into the protein's involvement in intracellular dynamics and homeostasis.
Chemically, CCDC107 inhibitors often exhibit specificity in binding due to their interaction with the protein's coiled-coil domains, a common structural motif involved in protein-protein interactions. The synthesis of such inhibitors can involve a range of strategies, including small molecule design, peptide-based inhibitors, and even high-throughput screening to identify lead compounds. The development of these inhibitors is driven by the need to better understand the role of CCDC107 in processes such as calcium signaling, vesicular transport, and membrane stabilization. By fine-tuning these inhibitors, researchers can selectively modulate CCDC107 activity in vitro, helping to elucidate the biochemical pathways in which it participates and its structural role in maintaining cellular organization. The study of CCDC107 inhibition can thus expand our understanding of cellular regulatory mechanisms and provide a basis for future biochemical research into protein functionality.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can disrupt multiple signaling pathways and may affect CCDC107-related processes. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90 and might interfere with its chaperone activity, potentially altering CCDC107 folding or function. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA polymerase by preventing RNA synthesis, which can downregulate CCDC107 expression. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Can modulate cellular signaling pathways by affecting dopamine receptors, which may indirectly influence CCDC107 activity. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A V-ATPase inhibitor that can disrupt endosomal-lysosomal acidification, potentially impacting CCDC107 trafficking. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can prevent ERK activation, potentially affecting signaling pathways involving CCDC107. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K and can alter the PI3K/AKT pathway, which may influence CCDC107-related processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR and can affect protein synthesis pathways that involve CCDC107. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin and can disrupt signaling pathways related to CCDC107. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, can modulate stress responses and signaling pathways that may involve CCDC107. | ||||||